Clinical Trial Update: Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10 [Phase 1]

View source ↗

Summary

Phase 1 trial update on lofexidine for treatment of opiate withdrawal has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• LOFEXIDINE (LOFEXIDINE)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid-Related Disorders | Phase 1 | Status: COMPLETED